These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 25560860)
1. Breathomics in lung disease. van der Schee MP; Paff T; Brinkman P; van Aalderen WMC; Haarman EG; Sterk PJ Chest; 2015 Jan; 147(1):224-231. PubMed ID: 25560860 [TBL] [Abstract][Full Text] [Related]
2. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. van de Kant KD; van der Sande LJ; Jöbsis Q; van Schayck OC; Dompeling E Respir Res; 2012 Dec; 13(1):117. PubMed ID: 23259710 [TBL] [Abstract][Full Text] [Related]
3. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys? van Mastrigt E; de Jongste JC; Pijnenburg MW Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891 [TBL] [Abstract][Full Text] [Related]
4. Sensors for detecting pulmonary diseases from exhaled breath. Hashoul D; Haick H Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31243097 [TBL] [Abstract][Full Text] [Related]
5. Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases. Ibrahim W; Carr L; Cordell R; Wilde MJ; Salman D; Monks PS; Thomas P; Brightling CE; Siddiqui S; Greening NJ Thorax; 2021 May; 76(5):514-521. PubMed ID: 33414240 [TBL] [Abstract][Full Text] [Related]
7. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
8. The versatile use of exhaled volatile organic compounds in human health and disease. Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865 [TBL] [Abstract][Full Text] [Related]
9. Analyses of lung cancer-derived volatiles in exhaled breath and Choueiry F; Barham A; Zhu J Exp Biol Med (Maywood); 2022 Jul; 247(13):1179-1190. PubMed ID: 35410512 [TBL] [Abstract][Full Text] [Related]
10. Exhaled breath condensate biomarkers in COPD. Borrill ZL; Roy K; Singh D Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788 [TBL] [Abstract][Full Text] [Related]
11. Exhaled breath analysis by electronic nose in respiratory diseases. Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642 [TBL] [Abstract][Full Text] [Related]
13. Breathomics from exhaled volatile organic compounds in pediatric asthma. Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668 [TBL] [Abstract][Full Text] [Related]
14. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Horváth I; Barnes PJ; Loukides S; Sterk PJ; Högman M; Olin AC; Amann A; Antus B; Baraldi E; Bikov A; Boots AW; Bos LD; Brinkman P; Bucca C; Carpagnano GE; Corradi M; Cristescu S; de Jongste JC; Dinh-Xuan AT; Dompeling E; Fens N; Fowler S; Hohlfeld JM; Holz O; Jöbsis Q; Van De Kant K; Knobel HH; Kostikas K; Lehtimäki L; Lundberg J; Montuschi P; Van Muylem A; Pennazza G; Reinhold P; Ricciardolo FLM; Rosias P; Santonico M; van der Schee MP; van Schooten FJ; Spanevello A; Tonia T; Vink TJ Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446552 [TBL] [Abstract][Full Text] [Related]
15. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760 [TBL] [Abstract][Full Text] [Related]
16. Influence of Sensory Stimulation on Exhaled Volatile Organic Compounds. Mazzatenta A; Pokorski M; Di Tano A; Cacchio M; Di Giulio C Adv Exp Med Biol; 2016; 884():75-9. PubMed ID: 26453064 [TBL] [Abstract][Full Text] [Related]
17. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018 [TBL] [Abstract][Full Text] [Related]
18. Exhaled breath analysis: from occupational to respiratory medicine. Corradi M; Mutti A Acta Biomed; 2005; 76 Suppl 2(Suppl 2):20-9. PubMed ID: 16353343 [TBL] [Abstract][Full Text] [Related]
19. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air. Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084 [TBL] [Abstract][Full Text] [Related]
20. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]